Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of metabolism/homeostasis (HP:0001939)help
Parent Node:
expand
Abnormal circulating protein concentration (HP:0010876)help
..Starting node
..expand
Abnormal circulating thyroglobulin level (HP:0025483)help
Term ID: 25483
Name: Abnormal circulating thyroglobulin level
Synonym:
Definition: A deviation from the normal concentration of thyroglobulin, a protein produced in the thyroid gland that acts as a precursor to thyrroid hormones.
Comments:
Reference: HP:0025483
Genes and Diseases:
 
       Child Nodes:
........expandIncreased circulating thyroglobulin level (HP:0025484) help

 Sister Nodes: 
..expandAbnormal B-type natriuretic peptide level (HP:0031138) help
..expandAbnormal circulating albumin concentration (HP:0012116) help
..expandAbnormal circulating apolipoprotein concentration (HP:0025201) help
..expandAbnormal circulating beta globulin level (HP:0025465) help
..expandAbnormal circulating beta-C-terminal telopeptide concentration (HP:0031424) help
..expandAbnormal hepcidin level (HP:0031875) help
..expandAbnormal insulin like growth factor binding protein acid labile subunit level (HP:0031034) help
..expandAbnormal levels of alpha-fetoprotein (HP:0045056) help
..expandAbnormal retinol-binding protein level (HP:0031031) help
..expandAbnormality of circulating enzyme level (HP:0011021) help
..expandAbnormality of the kinin-kallikrein system (HP:0005559) help
..expandDecreased prealbumin level (HP:0031085) help
..expandElevated carcinoembryonic antigen level (HP:0031029) help
..expandElevated carcinoma antigen 125 level (HP:0031030) help
..expandElevated circulating C-reactive protein concentration (HP:0011227) help
..expandElevated prostate-specific antigen level (HP:0025020) help
..expandHyperpepsinogenemia I (HP:0003238) help
..expandHyperproteinemia (HP:0002152) help
..expandHypoproteinemia (HP:0003075) help
..expandIncreased circulating thyroxine-binding globulin level (HP:0031222) help
..expandReduced growth-hormone binding protein level (HP:0031036) help
..expandReduced insulin-like factor 3 level (HP:0031037) help
..expandReduced sex -hormone binding protein level (HP:0031419) help
..expandReduced thyroxin-binding globulin (HP:0012509) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0DUOX2 CL E G H5050613273ORPHA:95716Familial thyroid dyshormonogenesisHP:0040283 - Occasional121
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0DUOX2 CL E G H5050613273ORPHA:226316Genetic transient congenital hypothyroidism121
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0DUOXA2 CL E G H40575332698ORPHA:95716Familial thyroid dyshormonogenesisHP:0040283 - Occasional11
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0FOXI1 CL E G H22993815OMIM:274600Pendred syndrome33
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0IYD CL E G H38943421071ORPHA:95716Familial thyroid dyshormonogenesisHP:0040283 - Occasional130
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0KCNJ10 CL E G H37666256OMIM:274600Pendred syndrome121
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0PAX8 CL E G H78498622OMIM:218700Hypothyroidism, congenital, nongoitrous, 263
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0SLC26A4 CL E G H51728818OMIM:274600Pendred syndrome274
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0SLC35A2 CL E G H735511022ORPHA:356961SLC35A2-CDG27
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0SLC5A5 CL E G H652811040ORPHA:95716Familial thyroid dyshormonogenesisHP:0040283 - Occasional59
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0TG CL E G H703811764ORPHA:95716Familial thyroid dyshormonogenesisHP:0040283 - Occasional155
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0THRB CL E G H706811799OMIM:188570Thyroid hormone resistance, generalized, autosomal dominant161
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0TPO CL E G H717312015ORPHA:95716Familial thyroid dyshormonogenesisHP:0040283 - Occasional92
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0TRHR CL E G H720112299ORPHA:99832Resistance to thyrotropin-releasing hormone syndromeHP:0040282 - Frequent2
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0TSHB CL E G H725212372ORPHA:90674Isolated thyroid-stimulating hormone deficiencyHP:0040281 - Very frequent9
HP:0025483HP:0025483Abnormal circulating thyroglobulin level0TSHR CL E G H725312373ORPHA:90673Hypothyroidism due to TSH receptor mutations97
HP:0025483HP:0025484Increased circulating thyroglobulin level1DUOX2 CL E G H5050613273ORPHA:226316Genetic transient congenital hypothyroidismHP:0040282 - Frequent121
HP:0025483HP:0025484Increased circulating thyroglobulin level1FOXI1 CL E G H22993815OMIM:274600Pendred syndrome33
HP:0025483HP:0025484Increased circulating thyroglobulin level1KCNJ10 CL E G H37666256OMIM:274600Pendred syndrome121
HP:0025483HP:0025484Increased circulating thyroglobulin level1PAX8 CL E G H78498622OMIM:218700Hypothyroidism, congenital, nongoitrous, 263
HP:0025483HP:0025484Increased circulating thyroglobulin level1SLC26A4 CL E G H51728818OMIM:274600Pendred syndrome274
HP:0025483HP:0025484Increased circulating thyroglobulin level1SLC35A2 CL E G H735511022ORPHA:356961SLC35A2-CDGHP:0040284 - Very rare27
HP:0025483HP:0025484Increased circulating thyroglobulin level1THRB CL E G H706811799OMIM:188570Thyroid hormone resistance, generalized, autosomal dominant161
HP:0025483HP:0025484Increased circulating thyroglobulin level1TSHR CL E G H725312373ORPHA:90673Hypothyroidism due to TSH receptor mutationsHP:0040282 - Frequent97


Genes (15) :DUOX2 DUOXA2 FOXI1 IYD KCNJ10 PAX8 SLC26A4 SLC35A2 SLC5A5 TG THRB TPO TRHR TSHB TSHR

Diseases (9) :ORPHA:95716 ORPHA:226316 OMIM:274600 OMIM:218700 ORPHA:356961 OMIM:188570 ORPHA:99832 ORPHA:90674 ORPHA:90673
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.